 |
 |
 |
|
Hepatitis C and Renal Disease: Differences in
Patient Characteristics and Clinical Outcomes in the United States
|
|
|
Reported by Jules Levin
AASLD 2015 Nov 13-17 San Francisco
Senaka Peter1; Craig Solid2; Tanya Bovitz2; Haifeng Guo2; Allan J. Collins2 Jean Marie Arduino1
1Merck & Co., Inc., Kenilworth, NJ, USA; 2Chronic Disease Research Group, Minneapolis, MN, USA





|
|
|
 |
 |
|
|